What is the ticker symbol for Ernexa Therapeutics?

Ernexa Therapeutics trades under the ticker ERNA on NASDAQ.

What sector does Ernexa Therapeutics operate in?

Ernexa Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ERNA in a portfolio?

PortView shows ERNA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Ernexa Therapeutics (ERNA) Stock Analysis

NASDAQHealthcareBiotechnology

$4.42+1.61%

1-year price historyRange $3.28 – $47.00

52-week range$4.42

$3.18$71.50

What Ernexa Therapeutics does

Ernexa Therapeutics Inc. is a biotechnology firm currently in its preclinical development phase, specializing in the creation of therapeutic interventions using induced mesenchymal stem cells (iMSCs). The company's primary focus lies in addressing solid tumor cancers and a range of autoimmune diseases. Its flagship candidate, ERNA-101, is an allogeneic iMSC designed to release pro-inflammatory cytokines, namely IL-7 and IL-15, intended for the treatment of ovarian cancer. Additionally, Ernexa is developing ERNA-102, an iMSC product engineered to secrete the anti-inflammatory cytokine IL-10, aimed at managing rheumatoid arthritis. The company has a licensing arrangement in place with Factor Bioscience Limited. Established in 2018, this Cambridge, Massachusetts-based entity operated as Eterna Therapeutics Inc. until its rebranding to Ernexa Therapeutics in March 2025.

Key metrics

Market cap

$1.39M

P/E (TTM)

-0.56

EPS (TTM)

$-7.96

Beta

2.56

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$5.07

200-day avg

$13.57

52-week high

$71.50

52-week low

$3.18

CEO

Sanjeev Luther

ETFs linked to ERNA

Broad-market and Healthcare sector ETFs an investor holding Ernexa Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ERNA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ERNA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Ernexa Therapeutics?: Ernexa Therapeutics trades under the ticker ERNA on NASDAQ.
Which exchange is ERNA listed on?: ERNA is listed on NASDAQ.
What sector does Ernexa Therapeutics operate in?: Ernexa Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ERNA in a portfolio?: PortView shows ERNA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.